Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I (2020) Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. J Neurol 267:715–720 DOI: 10.1007/s00415-019-09614-4
Jia L, Zhang H (2020) Axonal form of Guillain-Barré syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci. 10.1007/s10072-020-04560-w
Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N (2004) Does Campylobacter jejuni infection elicit “demyelinating” Guillain-Barre syndrome? Neurology 63:529–533 DOI: 10.1212/01.WNL.0000133205.05169.04
Tyberghein M, Milants C, Bouquiaux O, Wang F (2020) Axonal form of Guillain-Barré syndrome in a patient receiving oxaliplatin-based chemotherapy. Neurol Sci 41:1611–1613. 10.1007/s10072-019-04199-2 DOI: 10.1007/s10072-019-04199-2
